We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Gynaecological (endometrium, cervix, vagina, vulva)
6014
Digital Poster
Clinical
Uterine Perforation During Image-Guided Adaptive Brachytherapy in Cervical Cancer Patients
Guler Yavas, Turkey
PO-1278
68Gy EQD2 CONSTRAINT FOR G2-VAGINAL SHORTENING IN POST-OPERATIVE ENDOMETRIUM. PRELIMINARY RESULTS.
Angeles Rovirosa, Spain
PO-1279
Albumin-to-alkaline phosphatase ratio is not a predictor of survival in cervical cancer patients
Cem Onal, Turkey
PO-1280
The prognostic significance of the albumin and globulin levels in cervical cancer patients
Cem Onal, Turkey
PO-1281
Single Institution Outcomes for CT Guided Brachytherapy for Cervical Cancer
Mahvish Tariq Elahi, United Kingdom
PO-1282
MR-guided radiotherapy of gynecologic cancer – preliminary outcome data from a small cohort study
Anja Ør Knudsen, Denmark
PO-1284
Postoperative high dose rate brachytherapy in endometrial cancer: three versus six fractions.
Laura Cardoso Rubio, Spain
PO-1285
Prognostic factors for non-endometrioid carcinoma
Jose Antonio Domínguez Rullán, Spain
PO-1286
Target Deformation and Intrafraction Motion Errors in LRCTV for MR-guided Cervix Cancer Radiotherapy
Ian Zing Tan, United Kingdom
PO-1287
Sequential external beam RT boost with two simultaneous dose levels in advanced cervical cancer
Cristina Mariucci, Italy
PO-1288
Comparison of MRI Assessment and Clinical Evaluation of Disease Extent in Carcinoma Cervix Patients
Satyajit Pradhan, India
PO-1289
Effect of radiotherapy in addition to surgery in early stage endometrial cancer
Daniel Medenwald, Germany
PO-1290
Can we safely lower the RT dose with the use of high dose PF for advanced cervical cancer?
Mariko Kawamura, Japan
PO-1291
Results of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer
Valentina Lancellotta, Italy
PO-1292
Dosimetric predictors of brachytherapy in cervical cancer: an experience from a developing country
Elena Manea, Romania
PO-1293
Timing to assess the clinical response after chemoradiotherapy in locally advanced cervical cancer
ROSA AUTORINO, Italy
PO-1294
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy is not feasible
Tae Hoon Lee, Korea Republic of
PO-1295
Usage of PET/CT as a post-treatment surveillance strategy in locoregionally advanced cervical cancer
Nikola Cihoric, Switzerland
PO-1296
Machine Learning Identifies Predicators of Disease-Free Survival in Patients with Cervical Cancer
Emi Yoshida, USA
PO-1297
Parameters predicting intestinal toxicity in cervical cancer patients with adjuvant radiotherapy
Bichun Xu, China
PO-1298
Outcomes of cervical cancer patients treated with hybrid CT-X Ray based intracavitary applications.
Prachi Sawant, India
PO-1299
Stereotactic Body Radiation Therapy for oligometastatic lymph-nodal relapses in gynecological cancer
GIUSEPPINA MANDURINO, Italy
PO-1300
THE ROLE OF 18F-FDG PET/CT AND PELVIC MRI AFTER CONCURRENT CHEMO-RADIOTHERAPY
Valentina Lancellotta, Italy
PO-1301
Intraoperative electron radiation after salvage surgery in gynecological cancers and sarcomas
gabriela oses gonzalez, Spain
PO-1302
FDG-PET/CT AND MRI IN THE RADIOTHERAPY TREATMENT PLANNING OF LOCALLY ADVANCED CERVIX CANCER
ROSA AUTORINO, Italy
PO-1303
Acute hematological and metabolical side effects of chemoradiotherapy for inoperabl cervical cancer
Esma Didem Nasuhbeyoglu, Turkey
PO-1304
Radiation Therapy for Stage IVB Uterine Cervical Cancer with Supraclavicular Lymph Nodes Metastases
Yuki Mukai, Japan
PO-1305
apatinib plus capecitabine in patients of recurrent/metastatic and persistent cervical cancer
Jiehui Li, China
PO-1306
Extended nodal radiotherapy for relapsed gynecologic tumors with PET/CT-guided SIB
Stefano Lorenzo Villa, Italy
PO-1307
Image-guided helical/volumetric IMRT in vulvar cancer: results of a mono-institutional experience
Roberta Tummineri, Italy
PO-1308
IMRT in vulvar cancer: dismal outcomes from a retrospective single-center analysis.
Martina Ferioli, Italy
PO-1309
Salvage (re)radiation in oligo-recurrent and oligo-metastatic cervical cancer
Supriya Chopra, India
PO-1310
MR-guided SBRT boost for patients with recurrent gynecological cancers ineligible for brachytherapy
Indrawati Hadi, Germany
PO-1311
Quality of life in locally advanced cervical cancer: brachytherapy vs surgery after chemoradiation.
Martina Ferioli, Italy
PO-1312
Evaluation of CBCT-based auto-segmentation for online adaptive radiotherapy in cervical cancer
Charlotte Shelley, United Kingdom
PO-1313
Magnetic Resonance guided radiotherapy (MRgRT) in Gynaecological cancer: targets and gains
Manasi Ingle, United Kingdom
PO-1314
Treatment toxicities of cervical cancer with or without HIV infection in Botswana 2013-2020
Shawna Tuli, USA
PO-1315